Business Services Industry
Griffin Securities, Inc. Announces Investment Opinion on Clinical Data, Inc.
Business Wire, June 22, 2009
NEW YORK -- Griffin Securities, Inc. updated research coverage on Clinical Data, Inc. (NasdaqGM: CLDA) with a BUY Rating and a 12-month price target of $38.00.
Griffin Securities, Inc. specializes in identifying small cap emerging growth investment opportunities. The firm is a member of the Financial Industry Regulatory Authority (FINRA Broker ID 43229) and the Securities Investor Protection Corporation.
For a copy of the report, including disclosures, contact:
Chrystyna Bedrij
Griffin Securities, Inc.
212-509-9500
Copyright Business Wire 2009
Most Recent Business Articles
- Multiple criteria evaluation and optimization of transportation systems
- Multi-criteria analysis procedure for sustainable mobility evaluation in urban areas
- A two-leveled multi-objective symbiotic evolutionary algorithm for the hub and spoke location problem
- Multi-criteria analysis for evaluating the impacts of intelligent speed adaptation
- The development of Taiwan arterial traffic-adaptive signal control system and its field test: a Taiwan experience
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FAS 109: a primer for non-accountants - Financial Accounting Standards Board's "Statement 109: Accounting for Income Taxes"
- Design a commission plan that drives sales - Sales Commissions
- Too Young to Rent a Car? - 25-years-old the minimum age for car renting - Brief Article
- LIFO vs. FIFO: a return to the basics
Most Popular Business Publications
Content provided in partnership with
